Clinical Services

'Spider web' mechanism traps and kills viruses

12 July, 2021

Immunologists at Canada's McMaster University have discovered a mechanism that acts like a spider web — trapping and killing pathogens such as influenza or SARS-CoV-2.


The pitfalls of using multiple products for cleaning and disinfection

08 July, 2021 | Supplied by: Anaeron Pty Ltd

It is critical that different products are not used in the same environment, as some may react with each another, having unwanted and sometimes very hazardous effects.


PBS listing for ulcerative colitis treatment

05 July, 2021

Australians living with moderate-to-severe ulcerative colitis can now access a PBS-listed oral treatment alternative.


Whiteley Surfex dry-surface biofilm remover and disinfectant

01 July, 2021 | Supplied by: Whiteley

Surfex from Whiteley Medical is a dry-surface biofilm remover and disinfectant, intended for use on environmental surfaces and for non-critical medical devices such as hospital beds and theatre trolleys.


CleanSpace Technology CleanSpace Respirators

01 July, 2021 | Supplied by: CleanSpace Technology Pty Ltd

CleanSpace Technology's CleanSpace Respirators are designed to protect healthcare workers from airborne contaminants.


New treatment for asbestos-related cancer

01 July, 2021

Australians living with inoperable malignant mesothelioma will soon have access to an immunotherapy listed on the Pharmaceutical Benefits Scheme.


Global collaboration strives to advance heart health

30 June, 2021

The Global Cardiovascular Research Funders Forum aims to to advance the prevention, diagnosis and treatment of cardiovascular conditions such as heart attack and stroke.


What's Australia's first local Pfizer-style COVID vaccine? And when might it be in our arms? An mRNA expert explains

25 June, 2021 by Archa Fox Associate Professor and ARC Future Fellow, The University of Western Australia

A research team at Monash University hopes to develop a new mRNA vaccine, which works by the same principles as the Pfizer vaccine and could be manufactured locally.


Flinders University joins male health research alliance

23 June, 2021

Flinders University has become a research partner of the Freemasons Centre for Male Health & Wellbeing, broadening the scope and footprint of the centre's activities.


Fish oil's role in stopping superbugs

22 June, 2021

Australian scientists have discovered that regular fish oil has the potential to break down superbugs' ability to become resistant to antibiotics.


PanKind initiative sets sights on early detection of pancreatic cancer

21 June, 2021

PanKind has launched the PanKind Early Detection Initiative in a move to strategically work with the research community to improve early diagnosis of pancreatic cancer.


Increased options for infection prevention and bed flow managers

18 June, 2021 by Kate Smith (RN/RM, CRNI, GCertNurs, Cert IV TAA), Head of Clinical Solutions, Training and Support, GAMA Healthcare | Supplied by: GAMA Healthcare

Rediroom provides an instant and mobile patient isolation solution increasing bed management options for Infection Prevention Teams and Bed Flow Managers.


Promising results from Novavax Phase 3 vaccine trial

18 June, 2021

Novavax's COVID-19 vaccine demonstrated 100% protection against moderate and severe disease, with 90.4% efficacy overall, in the PREVENT-19 Phase 3 trial.


How to avoid dangerous mistakes when responding to anaphylaxis

18 June, 2021

World Allergy Week is seeking to raise awareness of allergies and anaphylaxis, with leading allergy organisations promoting important resources that could save lives.


Hope after hip fracture with new registry toolbox launch

17 June, 2021

The Hip Fracture Registry Toolbox is a practical and informative resource that explains the need, and how to best advocate, for the establishment of a national hip fracture registry.


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd